Effects of levonorgestrel-releasing intrauterine system on glucose and lipid metabolism: a 1-year follow-up study.

Abstract:

PURPOSE:This prospective study aimed to assess the possible effects of the levonorgestrel-releasing intrauterine system (LNG-IUS) on serum lipids and fasting blood glucose levels over a period of 1 year. METHODS:Forty-eight premenopausal women, attending our gynecology clinic with the complaint of menorrhagia, were enrolled in the study. Systolic and diastolic blood pressures were recorded. Serum concentrations of total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol (VLDL-C), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and fasting plasma glucose (FPG) levels were tested before (pretreatment group) and 1 year later following insertion (on-treatment group). Baseline mean parameters were compared with mean parameters at 1 year for statistical significance using paired samples t-test. RESULTS:Thirty-three (68.75%) women were eligible for control in the on-treatment group. Mean age of the patients was 44.34+/-7.59 years. The study results showed that mean FPG level was significantly increased, whereas mean diastolic blood pressure was significantly decreased. Although mean systolic blood pressure tended to decrease and HDL-C concentrations to increase, these changes from baseline levels were insignificant. There were no significant changes in mean TG, TC, VLDL, LDL, AST and ALT. DISCUSSION:The only significant unfavorable effect observed was an increase in FPG level. Since it did not rise to risky values, but alerted us for the high risk patients for glucose intolerance before insertion. The LNG-IUS can be regarded as being safe in their effects on lipid metabolism, blood pressure and liver function tests.

journal_name

Contraception

journal_title

Contraception

authors

Kayikcioglu F,Gunes M,Ozdegirmenci O,Haberal A

doi

10.1016/j.contraception.2005.12.005

subject

Has Abstract

pub_date

2006-05-01 00:00:00

pages

528-31

issue

5

eissn

0010-7824

issn

1879-0518

pii

S0010-7824(05)00485-3

journal_volume

73

pub_type

杂志文章
  • Extending contraceptive coverage under the Affordable Care Act saves public funds.

    abstract:BACKGROUND:The Affordable Care Act (ACA) will expand health care coverage to low-income Americans. Contraception services are a mandated component of ACA plans. STUDY DESIGN:A decision-analytic model was developed to compare the costs and outcomes of the current versus the proposed plan for contraceptive coverage (Fed...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2012.06.009

    authors: Burlone S,Edelman AB,Caughey AB,Trussell J,Dantas S,Rodriguez MI

    更新日期:2013-02-01 00:00:00

  • Ovarian function, bleeding control and serum lipoproteins in women using contraceptive vaginal rings releasing five different progestins.

    abstract::Ovarian function, bleeding patterns and serum lipoproteins were studied in women using contraceptive vaginal rings (CVRs) of dimethyl-polysiloxane impregnated with steroids. The different CVRs were used for about 10 cycles each. The following groups were studied, with the daily steroid dosage given in parentheses. Wom...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(83)90033-1

    authors: Ahrén T,Victor A,Lithell H,Vessby B,Jackanicz TM,Johansson ED

    更新日期:1983-10-01 00:00:00

  • An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive.

    abstract:BACKGROUND:Transdermal delivery of steroids is gaining popularity for contraception and hormone replacement therapy. This study aimed to test metered spray delivery of a precise dosage of Nestorone (NES) progestogen as a possible transdermal progestogen-only contraceptive. STUDY DESIGN:Six healthy postmenopausal volun...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2007.08.006

    authors: Fraser IS,Weisberg E,Kumar N,Kumar S,Humberstone AJ,McCrossin L,Shaw D,Tsong YY,Sitruk-Ware R

    更新日期:2007-12-01 00:00:00

  • Serum prolactin concentrations related to copper or inert intrauterine devices (IUDs) in women.

    abstract::A report that serum prolactin concentrations were almost doubled by the use of copper IUDs led us to study the effect of both copper and inert IUDs. We studied 105 normal women in whom all other prolactinergic factors had been excluded; 25 of them were using copper IUDs, 25 were using inert IUDs and there were 55 cont...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(79)90049-0

    authors: Ransom WT,Chapman RS,Hull MG

    更新日期:1979-11-01 00:00:00

  • Lactobacillus species isolated from the vagina: identification, hydrogen peroxide production and nonoxynol-9 resistance.

    abstract:BACKGROUND:Lactic acid production is considered to be the major protection mechanism of lactobacilli against vaginal infections due to genital pathogens. Some species of Lactobacillus are also hydrogen peroxide (H(2)O(2)) producers. Nonoxynol-9 (N-9) is a nonionic detergent and is the active component of many spermicid...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2005.06.066

    authors: Pascual LM,Daniele MB,Pájaro C,Barberis L

    更新日期:2006-01-01 00:00:00

  • A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.

    abstract::In this open-label, randomized study we compared the influence of a new oral contraceptive containing 30 microg ethinylestradiol and 3 mg drospirenone (EE + DRSP = Yasmin), with a reference preparation containing 30 microg ethinylestradiol and 150 microg desogestrel (EE + DSG = Marvelon) on the lipid profile. The prim...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.contraception.2003.11.003

    authors: Gaspard U,Endrikat J,Desager JP,Buicu C,Gerlinger C,Heithecker R

    更新日期:2004-04-01 00:00:00

  • Oral administration of a water extract of Phytolacca dodecandra l'herit in mice--effects on reproduction.

    abstract::Experiments were conducted to determine whether oral administration of a water extract of P. dodecandra had significant effects on reproduction in mice. The work is based on earlier reports in this journal that butanol extracts of the berries of this plant had spermatocidal properties in vitro and blastocidal activity...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(87)80006-9

    authors: Mamo E,Worku M

    更新日期:1987-02-01 00:00:00

  • Use of erythromycin for nonsurgical female sterilization in West Bengal, India: a study of 790 cases.

    abstract:OBJECTIVE:Determine if erythromycin is an effective agent for achieving occlusion of the Fallopian tube for nonsurgical female sterilization. METHODS:Two studies of 100 healthy volunteers requesting sterilization were planned, one in Julpia Andhermanik and the other in Kolkata (Calcutta). A readily available marketed ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2003.07.005

    authors: Bairagy NR,Mullick BC

    更新日期:2004-01-01 00:00:00

  • Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center.

    abstract:INTRODUCTION:To increase access to safe abortion in rural India, the feasibility and acceptability of mifepristone-misoprostol abortion was assessed in a typical government run primary health center (PHC) in Nagpur district, Maharashtra State, that does not offer surgical abortion services and must refer off-site for e...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2007.03.010

    authors: Mundle S,Elul B,Anand A,Kalyanwala S,Ughade S

    更新日期:2007-07-01 00:00:00

  • Objections to tubal sterilization: what reversibility can and cannot overcome.

    abstract::In a study of 1074 women, 696 and 338 subjects would not seriously consider permanent and hypothetically reversible sterilization, respectively; they were asked to explain their feelings. The reason accounting for most objections to permanent sterilization (65%) was irreversibility and of the subjects who would not co...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(80)80001-1

    authors: Shain RN

    更新日期:1980-09-01 00:00:00

  • The effect of depot-medroxyprogesterone acetate on the fetus and nursing infant: a review.

    abstract::Data from published studies of the quantity of medroxyprogesterone acetate and/or its metabolites in the milk of lactating women receiving Depo-Provera for contraception is extrapolated into the amount of drug ingested daily by a theoretically average infant. Comparisons are made with the results of similar studies in...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/0010-7824(81)90027-5

    authors: Schwallie PC

    更新日期:1981-04-01 00:00:00

  • Early abortion services in the United States: a provider survey.

    abstract::The objective of this study was to describe the availability of early surgical and medical abortion among members of the National Abortion Federation (NAF) and to identify factors affecting the integration of early abortion services into current services. Telephone interviews were conducted with staff at 113 Planned P...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(02)00512-7

    authors: Benson J,Clark KA,Gerhardt A,Randall L,Dudley S

    更新日期:2003-04-01 00:00:00

  • Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception.

    abstract:OBJECTIVE:This study aims to compare the cost-effectiveness of oral contraceptives (OCs), the levonorgestrel-releasing intrauterine system (LNG-IUS) and surgical management in treating dysfunctional uterine bleeding (DUB) in women not desiring additional children. METHOD:A Markov model was constructed from the perspec...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2006.03.024

    authors: Blumenthal PD,Trussell J,Singh RH,Guo A,Borenstein J,Dubois RW,Liu Z

    更新日期:2006-09-01 00:00:00

  • Contraceptive use at last intercourse among reproductive-aged women with disabilities: an analysis of population-based data from seven states.

    abstract:OBJECTIVE:To assess patterns of contraceptive use at last intercourse among women with physical or cognitive disabilities compared to women without disabilities. STUDY DESIGN:We analyzed responses to 12 reproductive health questions added by seven states to their 2013 Behavioral Risk Factor Surveillance System questio...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2017.12.008

    authors: Haynes RM,Boulet SL,Fox MH,Carroll DD,Courtney-Long E,Warner L

    更新日期:2018-06-01 00:00:00

  • Women's out-of-pocket expenditures and dispensing patterns for oral contraceptive pills between 1996 and 2006.

    abstract:BACKGROUND:Little is known about the out-of-pocket expenditures and dispensing patterns for oral contraceptive pills (OCPs), factors associated with these outcomes and whether they change over time. STUDY DESIGN:Observational cohort using 1996-2006 Medical Expenditure Panel Surveys. RESULTS:Women spent $16 out-of-poc...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2010.09.013

    authors: Liang SY,Grossman D,Phillips KA

    更新日期:2011-06-01 00:00:00

  • Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.

    abstract::The potent luteinizing hormone-releasing hormone (LRH) agonist D-Ser(TBU)6-EA10-LRH was administered in a daily subcutaneous dose of 5 or 25 microgram for 1, 3 or 5 consecutive days to twelve regularly menstruating women in the early follicular phase of the menstrual cycle in an attempt to disturb follicular maturatio...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(82)90016-6

    authors: Skarin G,Nillius SJ,Wide L

    更新日期:1982-01-01 00:00:00

  • Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial.

    abstract:BACKGROUND:Barriers to intrauterine device (IUD) use in nulliparous women include fear of pain with insertion and provider perception of difficulty with insertion. The goal of this study was to evaluate whether misoprostol prior to IUD insertion in nulliparous women eased insertion and decreased pain. STUDY DESIGN:Thi...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2013.07.011

    authors: Lathrop E,Haddad L,McWhorter CP,Goedken P

    更新日期:2013-12-01 00:00:00

  • Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive.

    abstract::This randomized, double-blind, placebo-controlled exploratory study examined the efficacy and safety of a low-dose oral contraceptive (Mircette), desogestrel/ethinyl estradiol [DSG/EE] and ethinyl estradiol [EE]) in relieving the symptoms of dysmenorrhea. Twenty-three clinics in the United States enrolled 77 women (ag...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0010-7824(02)00414-6

    authors: Hendrix SL,Alexander NJ

    更新日期:2002-12-01 00:00:00

  • A study of the relationship between tensile testing of condoms and breakage in use.

    abstract::The ability of the condom wall to maintain its integrity throughout sexual intercourse is critical to its role in halting the spread of major sexually transmissible pathogens including the human immunodeficiency virus. There are three principal in vitro performance tests applied to condoms: a test for freedom from hol...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(91)90045-h

    authors: Gerofi J,Shelley G,Donovan B

    更新日期:1991-02-01 00:00:00

  • Buccal misoprostol as cervical preparation for second trimester pregnancy termination.

    abstract::The objective of the study was to assess the efficacy of cervical preparation with misoprostol or laminaria suction abortion up to 18 weeks gestation. The study was conducted among a consecutive case series of patients presenting for dilatation and evacuation at a single center. Cervical preparation was effected by ei...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(02)00306-2

    authors: Todd CS,Soler M,Castleman L,Rogers MK,Blumenthal PD

    更新日期:2002-06-01 00:00:00

  • Has mifepristone medical abortion expanded abortion access in New Mexico? A survey of OB-GYN and Family Medicine physicians.

    abstract:BACKGROUND:The FDA approval of mifepristone in 2000 broadened the available options for abortion. The aim of this study was to evaluate whether physicians in New Mexico have integrated the use of mifepristone into their practice. STUDY DESIGN:We performed a mail-out survey of New Mexico Obstetrician Gynecologists (Ob-...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2010.11.021

    authors: Espey E,Leeman L,Ogburn T,Skipper B,Eyman C,North M

    更新日期:2011-08-01 00:00:00

  • Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review.

    abstract:BACKGROUND:Women with depressive or bipolar disorders are at an increased risk for unintended pregnancy. OBJECTIVE:To examine the safety of hormonal contraception among women with depressive and bipolar disorders. METHODS:We searched for articles published through January 2016 on the safety of using any hormonal cont...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2016.06.012

    authors: Pagano HP,Zapata LB,Berry-Bibee EN,Nanda K,Curtis KM

    更新日期:2016-12-01 00:00:00

  • Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.

    abstract::The metabolic and hemostatic effects of two oral contraceptives containing 150 mcg desogestrel and 20 mcg ethinyl-estradiol (EE) (MERCILON) or 30 mcg EE (MARVELON) were compared in order to examine the effect of reducing the EE dose in contraceptive pills. Forty-nine women participated in this randomized study during ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(93)90141-s

    authors: Basdevant A,Conard J,Pelissier C,Guyene TT,Lapousterle C,Mayer M,Guy-Grand B,Degrelle H

    更新日期:1993-09-01 00:00:00

  • Gestational dating using last menstrual period and bimanual exam for medication abortion in pharmacies and health centers in Nepal.

    abstract:OBJECTIVE:To evaluate whether conducting a bimanual examination prior to medication abortion (MAB) provision results in meaningful changes in gestational age (GA) assessment after patient-reported last menstrual period (LMP) in Nepal. STUDY DESIGN:Women ages 16-45 (n=660) seeking MAB at twelve participating pharmacies...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2018.06.004

    authors: Averbach S,Puri M,Blum M,Rocca C

    更新日期:2018-10-01 00:00:00

  • A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.

    abstract:OBJECTIVES:To evaluate the impact on lipid and carbohydrate variables of a combined one-third ethinyl estradiol (EE)/levonorgestrel (LNG) dose reduction in oral contraceptives. METHODS:In an open-label, randomized study, a dose-reduced oral contraceptive containing 20 microg EE and 100 microg LNG (20 EE/100 LNG) was c...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.contraception.2004.08.017

    authors: Skouby SO,Endrikat J,Düsterberg B,Schmidt W,Gerlinger C,Wessel J,Goldstein H,Jespersen J

    更新日期:2005-02-01 00:00:00

  • The collection and interpretation of epidemiological data about the cardiovascular risks associated with the use of steroid contraceptives.

    abstract::A variety of epidemiological approaches have been used to assess the safety of steroid contraceptives. Each study design has its own strengths and weaknesses, especially with respect to susceptibility to bias and confounding. Randomized controlled trials provide the strongest evidence of a cause and effect relationshi...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/s0010-7824(98)00013-4

    authors: Hannaford P

    更新日期:1998-03-01 00:00:00

  • Implications of dispensing self-administered hormonal contraceptives in a 1-year supply: a California case study.

    abstract::On September 23, 2016, California became the sixth state to pass legislation requiring health plans and insurers to cover a 12-month supply of FDA-approved self-administered hormonal contraceptives such as contraceptive pills, patches and vaginal rings. This legislation is estimated to result in 38% of current contrac...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2016.12.008

    authors: McMenamin SB,Charles SA,Tabatabaeepour N,Shigekawa E,Corbett G

    更新日期:2017-05-01 00:00:00

  • Contraceptive sterilization use among married men in the United States: results from the male sample of the National Survey of Family Growth.

    abstract:BACKGROUND:Surgical sterilization has many advantages. Previous information on prevalence and correlates was based on surveys of women. STUDY DESIGN:We estimated the prevalence of vasectomy and tubal ligation of partners for male participants in the 2002 National Survey of Family Growth, a nationally representative su...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2010.03.018

    authors: Anderson JE,Warner L,Jamieson DJ,Kissin DM,Nangia AK,Macaluso M

    更新日期:2010-09-01 00:00:00

  • Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route.

    abstract::Medically induced abortion using a new regimen of oral mifepristone 600 mg and vaginal misoprostol 800 micrograms (PGE1 analogue) was carried out in 100 women. Abortion occurred in all patients without resort to surgery. In 99 women, the abortion occurred within 4 hours of the administration of the prostaglandin. Sixt...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(94)90085-x

    authors: el-Refaey H,Templeton A

    更新日期:1994-02-01 00:00:00

  • Improving hysterosalpingogram confirmatory test follow-up after Essure hysteroscopic sterilization.

    abstract:BACKGROUND:Given the need for a 90-day post-Essure hysterosalpingogram (HSG) to confirm proper tubal placement and occlusion, we examined the impact of dedicating a staff nurse to schedule HSG appointments, call with appointment reminders and track HSG compliance for patients who had Essure. STUDY DESIGN:We performed ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2010.01.019

    authors: Guiahi M,Goldman KN,McElhinney MM,Olson CG

    更新日期:2010-06-01 00:00:00